梧桐國際(00613.HK)委聘邱惠擔任公司首次公開發售保薦業務負責人
格隆匯3月16日丨梧桐國際(00613.HK)公吿,公司的間接全資附屬公司亞貝隆為於香港根據證券及期貨條例進行第6類(就機構融資提供意見)受規管活動的持牌法團。其主要業務包括提供金融服務,例如就香港公司收購、合併及股份回購守則向客户提供意見,並就上市規則擔任香港上市公司的財務顧問。
集團的業務計劃為:透過參與首次公開發售保薦業務,擴闊亞貝隆的現有企業財務顧問業務的服務範疇,以為集團捕捉更多商機;及透過招募經驗豐富的專才成立首次公開發售團隊,擴充現有企業財務顧問業務。
為籌備展開集團的首次公開發售保薦業務,董事會欣然宣佈集團已委聘邱惠女士擔任發展本集團首次公開發售保薦業務的負責人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.